Drug Information

Drug General Information
Drug ID
D0I7IC
Former ID
DNC001216
Drug Name
RIS
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535372]
Structure
Download
2D MOL

3D MOL
Formula
C7H11NO7P2
Canonical SMILES
C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
InChI
1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)
InChIKey
IIDJRNMFWXDHID-UHFFFAOYSA-N
CAS Number
CAS 105462-24-6
PubChem Compound ID
5245
PubChem Substance ID
10432, 634947, 854702, 854710, 5611888, 7890278, 7980522, 8024683, 8153227, 14799749, 26717653, 29224300, 46506784, 46507526, 46513033, 48416522, 50064108, 50489232, 53790968, 56479319, 57322678, 81040440, 81063165, 92309057, 92712985, 93166168, 96025170, 103240839, 104308679, 125337191, 126625112, 126656394, 126670227, 128171553, 131293655, 134337947, 134340432, 135018951, 135650902, 135692314, 136990826, 137003756, 142093192, 143493311, 144080110, 152031983, 152242566, 160964225, 162178465, 164205287
SuperDrug ATC ID
M05BA07
SuperDrug CAS ID
cas=105462246
Target and Pathway
Target(s) Farnesyl pyrophosphatesynthetase Target Info Inhibitor [535372]
KEGG Pathway Terpenoid backbone biosynthesis
Metabolic pathways
Biosynthesis of antibiotics
Influenza A
HTLV-I infection
PathWhiz Pathway Steroid Biosynthesis
Reactome Cholesterol biosynthesis
Activation of gene expression by SREBF (SREBP)
WikiPathways Activation of Gene Expression by SREBP (SREBF)
SREBP signalling
Cholesterol Biosynthesis
References
Ref 535372In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrob Agents Chemother. 2002 Mar;46(3):929-31.
Ref 535372In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrob Agents Chemother. 2002 Mar;46(3):929-31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.